TY - JOUR AU - Khalili, J. S. AU - Hanson, R. W. AU - Szallasi, Z. PY - 2012 DA - 2012// TI - In silico prediction of tumor antigens derived from functional missense mutations of the cancer gene census JO - Oncoimmunology VL - 1 UR - https://doi.org/10.4161/onci.21511 DO - 10.4161/onci.21511 ID - Khalili2012 ER - TY - JOUR AU - Restifo, N. P. AU - Dudley, M. E. AU - Rosenberg, S. A. PY - 2012 DA - 2012// TI - Adoptive immunotherapy for cancer: harnessing the T cell response JO - Nat Rev Immunol VL - 12 UR - https://doi.org/10.1038/nri3191 DO - 10.1038/nri3191 ID - Restifo2012 ER - TY - JOUR AU - Wolfel, T. PY - 1995 DA - 1995// TI - A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma JO - Science VL - 269 UR - https://doi.org/10.1126/science.7652577 DO - 10.1126/science.7652577 ID - Wolfel1995 ER - TY - JOUR AU - Coulie, P. G. PY - 1995 DA - 1995// TI - A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma JO - Proc Natl Acad Sci USA VL - 92 UR - https://doi.org/10.1073/pnas.92.17.7976 DO - 10.1073/pnas.92.17.7976 ID - Coulie1995 ER - TY - JOUR AU - Echchakir, H. PY - 2001 DA - 2001// TI - A point mutation in the alpha-actinin-4 gene generates an antigenic peptide recognized by autologous cytolytic T lymphocytes on a human lung carcinoma JO - Cancer Res VL - 61 ID - Echchakir2001 ER - TY - JOUR AU - Lennerz, V. PY - 2005 DA - 2005// TI - The response of autologous T cells to a human melanoma is dominated by mutated neoantigens JO - Proc Natl Acad Sci USA VL - 102 UR - https://doi.org/10.1073/pnas.0500090102 DO - 10.1073/pnas.0500090102 ID - Lennerz2005 ER - TY - JOUR AU - Segal, N. H. PY - 2008 DA - 2008// TI - Epitope landscape in breast and colorectal cancer JO - Cancer Res VL - 68 UR - https://doi.org/10.1158/0008-5472.CAN-07-3095 DO - 10.1158/0008-5472.CAN-07-3095 ID - Segal2008 ER - TY - JOUR AU - Pieper, R. PY - 1999 DA - 1999// TI - Biochemical Identification of a Mutated Human Melanoma Antigen Recognized by CD4(+) T Cells JO - J Exp Med VL - 189 UR - https://doi.org/10.1084/jem.189.5.757 DO - 10.1084/jem.189.5.757 ID - Pieper1999 ER - TY - JOUR AU - Heemskerk, B. AU - Kvistborg, P. AU - Schumacher, T. N. PY - 2013 DA - 2013// TI - The cancer antigenome JO - EMBO J VL - 32 UR - https://doi.org/10.1038/emboj.2012.333 DO - 10.1038/emboj.2012.333 ID - Heemskerk2013 ER - TY - CHAP AU - Wolchok, J. D. PY - 2013 DA - 2013// TI - Nivolumab plus Ipilimumab in Advanced Melanoma BT - N Engl J Med ID - Wolchok2013 ER - TY - JOUR AU - Robbins, P. F. PY - 2013 DA - 2013// TI - Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3161 DO - 10.1038/nm.3161 ID - Robbins2013 ER - TY - JOUR AU - Walter, S. PY - 2012 DA - 2012// TI - Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival JO - Nat Med VL - 18 UR - https://doi.org/10.1038/nm.2883 DO - 10.1038/nm.2883 ID - Walter2012 ER - TY - JOUR AU - Hailemichael, Y. PY - 2013 DA - 2013// TI - Persistent antigen at vaccination sites induces tumor-specific CD8(+) T cell sequestration, dysfunction and deletion JO - Nat Med VL - 19 UR - https://doi.org/10.1038/nm.3105 DO - 10.1038/nm.3105 ID - Hailemichael2013 ER - TY - JOUR AU - Matsushita, H. PY - 2012 DA - 2012// TI - Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting JO - Nature VL - 482 UR - https://doi.org/10.1038/nature10755 DO - 10.1038/nature10755 ID - Matsushita2012 ER - TY - JOUR AU - Topalian, S. L. PY - 2012 DA - 2012// TI - Safety, activity, and immune correlates of anti-PD-1 antibody in cancer JO - N Engl J Med VL - 366 UR - https://doi.org/10.1056/NEJMoa1200690 DO - 10.1056/NEJMoa1200690 ID - Topalian2012 ER - TY - CHAP AU - Hamid, O. PY - 2013 DA - 2013// TI - Safety and Tumor Responses with Lambrolizumab (Anti-PD-1) in Melanoma BT - N Engl J Med ID - Hamid2013 ER - TY - JOUR AU - Castle, J. C. PY - 2012 DA - 2012// TI - Exploiting the mutanome for tumor vaccination JO - Cancer Res VL - 72 UR - https://doi.org/10.1158/0008-5472.CAN-11-3722 DO - 10.1158/0008-5472.CAN-11-3722 ID - Castle2012 ER - TY - JOUR AU - Bassani-Sternberg, M. PY - 2010 DA - 2010// TI - Soluble plasma HLA peptidome as a potential source for cancer biomarkers JO - Proc Natl Acad Sci USA VL - 107 UR - https://doi.org/10.1073/pnas.1008501107 DO - 10.1073/pnas.1008501107 ID - Bassani-Sternberg2010 ER -